Publications by authors named "Shiraj Sen"

Claim this Profile
A
Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid Tumors.
Jianhui Ma, Wen Liu, Jiali Li, Daehwan Kim, Sangyub Kim, Shiraj Sen

Mol Cancer Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi Study.
David Campbell, Scott Ramsey, David Veenstra, Minggui Pan, Shiraj Sen

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
Filip Janku, Milind M Javle, Shiraj Sen, Shubham Pant, Lindsay G Bramwell, Mary J Johansen

Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, Shiraj Sen, David S Hong

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice.
Carsten Schröder, Craig Gower-Page, Irmarie Reyes-Rivera, Arisha Patel, Richard Price, Shiraj Sen

JCO Clin Cancer Inform· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma.
Christine Chung, Rachael Galvin, Ella Achenbach, Oliwier Dziadkowiec, Shiraj Sen

Oncology (Williston Park)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications.
Roberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, Shiraj Sen, Brian A Van Tine

Curr Probl Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic vs Community Physicians.
Christine Chung, Rachael Galvin, Ella Achenbach, Oliwier Dziadkowiec, Shiraj Sen

Oncology (Williston Park)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P Model.
David C Norris, Shiraj Sen, Roman Groisberg, Vivek Subbiah

Mayo Clin Proc· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to Clinical Trial Enrollment in Patients With Pancreatic Adenocarcinoma Eligible for Early-Phase Clinical Trials.
Rachael Galvin, Christine Chung, Ella Achenbach, Oliwier Dziadkowiec, Shiraj Sen

Oncology (Williston Park)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histology-agnostic drug development - considering issues beyond the tissue.
Roberto Carmagnani Pestana, Shiraj Sen, Brian P Hobbs, David S Hong

Nat Rev Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Phase 1 Clinical Trials: An Opportunity to Evaluate Psychological States and Reeducate Patients on Prognosis?
Shiraj Sen, Sarah Moreland

Oncology (Williston Park)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of BRAF and mTOR in -mutant pediatric, adolescent, and young adult brain tumors.
Shiraj Sen, Ryuma Tanaka, Soumen Khatua, Wafik Zaky, Filip Janku

Cold Spring Harb Mol Case Stud· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Development in Soft Tissue Sarcomas: Novel Targets and Recent Early Phase Trial Results.
Ella Achenbach, David Lai, Shiraj Sen

J Immunother Precis Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, Robin K Kelley, Benjamin Tan

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.
Jason Roszik, Abir Khan, Anthony P Conley, J Andrew Livingston, Roman Groisberg, Shiraj Sen

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With -Mutated Malignancies.
Vivek Subbiah, Shiraj Sen, Kenneth R Hess, Filip Janku, David S Hong

JCO Precis Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.
Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P Macedo, Fernando Carapeto, Shiraj Sen

JCO Precis Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
Shiraj Sen, Shumei Kato, Rishi Agarwal, Sarina Piha-Paul, Kenneth Hess

Br J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
Shiraj Sen, Kenneth Hess, David S Hong, Aung Naing, Sarina Piha-Paul

Br J Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors.
Shiraj Sen, Funda Meric-Bernstam, David S Hong, Kenneth R Hess, Vivek Subbiah

J Natl Cancer Inst· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Roman Groisberg, David S Hong, Vijaykumar Holla, Filip Janku, Sarina Piha-Paul, Shiraj Sen

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of HIV-Associated Primary Effusion Lymphoma: A Single Center Experience.
Arjun Gupta, Shiraj Sen, Eileen Marley, Weina Chen, Harris V Naina

Clin Lymphoma Myeloma Leuk· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral Facial Nerve Palsy in Acute B Cell Lymphoblastic Leukemia: A Case Report and Review of the Literature.
Shiraj Sen, Arjun Gupta, Paul Friedman, Harris V Naina

Indian J Hematol Blood Transfus· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.
Arjun Gupta, Shiraj Sen, Harris Naina

BMJ Case Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis